Objective: Although cancer patients frequently experience self-perceived burden to others, this perception has not been enough studied. The aim of this study was to investigate the prevalence of selfperceived burden to the primary caregiver (SPB-PC) and associated factors in an older patient population with hematologic malignancies at the time of chemotherapy initiation.
Introduction
Patients with chronic illness frequently worry about being a burden to their families [1] . Although burden has been investigated from the caregiver's perspective [2] [3] [4] [5] [6] [7] , few studies have addressed patients' feeling of being a burden. Patients' self-perceived burden (SPB) refers to 'an empathic concern engendered from the impact on others of one's illness and care needs, resulting in guilt, distress, feelings of responsibility, and diminished sense of self' [8] (p425). SPB can have major consequences on patients' decision making, leading them to choose not to initiate treatment [9] , refuse life-extending medical treatment [10] , experience a diminished will to live [11] , desire hastened death [12, 13] , and/or prefer to receive end-of-life care in an institutional setting, rather than at home [14, 15] .
Patients' SPB may develop for various reasons. It may appear among subjects with functional limitations, reflecting social standards and ideals promoting autonomy, productivity, and successful aging [16] . It may arise from an imbalance between what a patient can contribute and what he or she receives in return when perceived possibilities to reduce the imbalance are limited or nonexistent [17, 18] . Patients' SPB may also arise from the internalization of different types of social norms and values regarding relationships with others [19] .
To our knowledge, SPB has rarely been studied in oncology, except in the context of palliative care. One study demonstrated that 65% of patients with advanced cancer experienced minimal SPB and 19% experienced moderate to extreme SPB [20] . Other studies have been conducted among patients with chronic pain or terminal illness to assess factors associated with SPB [21] [22] [23] . Among sociodemographic characteristics, an association was found with living only with a spouse (suggesting a higher SPB when patients lived only with their spouse versus only with other family members versus with their spouse and with other family members) [24] , whereas associations with age, gender, marital status, and education level have often been contradictory or absent [21] [22] [23] [24] [25] . Among psychological characteristics, patients' SPB has been correlated with psychological distress [26] , depression, worry about the future, decreased ability to concentrate [21] , poor perceived quality of life (QOL) [22] , loss of control, loss of dignity, hopelessness [25] , and suicidal ideation [27, 28] . Associated medical characteristics include a large number of comorbid conditions [22] and the presence of physical symptoms, such as pain, weakness, dyspnea [25] , and functional limitation [23, 29] . One study found no association between physical symptoms and SPB among terminally ill patients [21] ; the authors suggested that the impact of physical symptoms on SPB may have been outweighed by psychological discomfort. Among relationship characteristics, patients' SPB has been associated with greater caregiver burden [23] .
Available studies addressing patients' SPB have methodological limitations. They have been conducted as case studies [30] , and they have focused mainly on patients with terminal [30, 31] or chronic [23, 32] illness. Thus, the conclusions of these studies are not generalizable to other medical settings. Moreover, the persons to which patients refer when reporting SPB (primary caregiver versus others) have not been identified systematically.
SPB of older patients with cancer requires the attention of researchers and health care professionals for several reasons. First, older patients with cancer are potentially at greater risk of being a burden to their family and friends for long periods of time, considering their frequent loss of autonomy, physical and psychological discomfort, and frailties. Second, SPB may be a factor triggering suicide, which is frequent among older patients with cancer [33] . Third, as SPB has been shown to influence medical decision making, it must be better addressed in settings devoted to the care of older patients with cancer. Knowledge about SPB is important to improve the quality of support provided by health care professionals.
The aim of this study was to assess the prevalence of self-perceived burden to the primary caregiver (SPB-PC) in older patients with hematologic malignancies at the time of chemotherapy initiation. First, it has been chosen to look specifically to SPB-PC to study a precise subjective feeling which may be useful to consider in patients and their primary caregivers support. Second, the time of chemotherapy initiation was chosen because patients were considered by physicians to be sufficiently fit for the initiation of a new treatment, and their treatment response could be considered as a possible positive outcome. The treatment initiation period was thus considered suitable for the assessment of SPB-PC and associated factors to optimize support provided to patients and caregivers. Third, although there is not a strong rationale to study specifically a hematological population, such a population -versus a population presenting solid tumors -was considered for the purpose of this study as illness perception and symptoms burden may be specific [34] . Given the current lack of models to explain SPB-PC in older patients with cancer, we conducted exploratory analyses to assess associations with patient and patients'/primary caregivers' personal relationship characteristics. Most of factors reported in the literature as associated with SPB have been therefore considered.
Methods

Patients and setting
This study was conducted in six Belgian hospitals and was approved by the local ethics committee. All consecutive patient volunteers fulfilling the inclusion criteria were invited to participate and provided written informed consent. Recruited patients were aged ≥65 years, had hematologic malignancies, had been admitted for chemotherapy initiation, and were able to speak French. Patients hospitalized for palliative care, those with diagnoses of severe dementia, and those who could not complete scheduled assessments for physical or psychological reasons were excluded. The assessment conducted by several independent investigators was conducted during the 48 h around chemotherapy initiation and lasted approximately 1 -1.5 h. Therefore the assessment might have been conducted after the chemotherapy initiation. In order to avoid bias, self-reported questionnaires were used. Moreover the investigators were trained in order to standardize the way to present the study and the assessment. Considering the requirements of the local ethics committee, no information on non-respondents was collected.
Assessment tools
Self-perceived burden to the primary caregiver As the study was run in French, the use of a 100-mm visual analogue scale (VAS; ranging from 'not at all' to 'a lot') was chosen in order to minimize cross-languages ordinal and interval differences of response choices of a 5-point Likert scale.
Patients' sociodemographic and medical characteristics
Patients provided demographic information, including age, gender, educational level, marital status, and living status. Physicians provided patients' medical characteristics including diagnosis, time since diagnosis, disease status, prognosis, and number of comorbidities. Such as SPB-PC, VAS assessing patients' symptoms were used firstly to minimize cross-languages ordinal and interval differences of response choices and second to avoid a too long assessment period. Four VAS were used in order to assess current patients' levels of fatigue (ranging from 'not at all' to 'a lot'), pain (ranging from 'not at all' to 'a lot'), nausea (ranging from 'not at all' to 'a lot'), and QOL (ranging from 'very bad' to 'excellent').
Patients' physical functioning status and psychological characteristics
Patients' physical functioning status and psychological characteristics were assessed using validated tools: Karnofsky performance score, activities of daily living (Katz ADL [35] (total score ranged from 6 to 24) and Lawton IADL [36] (total score ranged from 8 to 32); higher score indicated better physical functioning status), Functional Assessment of Cancer Therapy Cognitive Scale version 3 (FACT-Cog), Hospital Anxiety and Depression Scale (HADS; higher score indicated higher psychological distress) [37] . As most of these tools are well known, only the FACT-Cog Scale will be detailed here.
The FACT-Cog Scale is a self-reported measure of cognitive impairments and its impact on patients QOL. This 37-item instrument assesses patients' memory, attention, concentration, language, and thinking abilities during the last 7 days. It consists of four subscales: perceived cognitive impairments (20 items; score range 0-80; higher score indicated frequent perceived impairments) and comments from others (4 items; score range 0-16; higher score indicated frequent comments from others) subscales; and perceived cognitive abilities (9 items; score range 0-36; higher score indicated higher perceived cognitive abilities) and impact on QOL (4 items; score range 0-16; higher score indicated higher impact on QOL) subscales [38] . The FACT-Cog questionnaire has been translated into French and validated with French-speaking patients with cancer [39] .
Patients'/primary caregivers' personal relationship characteristics
Patients were asked to characterize their personal ties with primary caregivers and to report the frequency of encounters (responses were grouped into two categories (a) 'less than every day' versus (b) 'every day'), frequency of discussions about the disease (responses were grouped into two categories (a) 'never, rarely or sometimes' versus (b) 'often or always'), frequency with which the primary caregiver helped the patient (responses were grouped into two categories (a) 'never, rarely or sometimes' versus (b) 'often or always') and assessment of the primary caregiver's ability to perceive the patient's difficulties (responses were grouped into two categories (a) 'excellent, very good or good' versus (b) 'average or poor').
Statistical analysis
There is no available recommendation on how to consider moderate to severe SPB-PC. Therefore, to assess the prevalence of moderate to severe SPB-PC, a cut-off score of ≥50 mm was chosen to consider a probably clinically significant SPB-PC. To assess associated factors, SPB-PC was considered as a continuous variable. Univariate relationships between patient characteristics and SPB-PC were evaluated using non-parametric tests (e.g. Spearman correlations, Mann-Whitney or Kruskal-Wallis test). All tests were two tailed and alpha was set at 0.05. A backward stepwise linear regression model was then computed to assess relationships between potential predictors and patients' SPB-PC. All variables with univariate p-values ≤ 0.05 were entered into the model. Variables were not entered in the model as separate blocks and no logtransformation was needed. Analyses were performed with SPSS software (version 20.0 for Windows; SPSS, Chicago, IL).
Results
Subjects
Among 293 eligible inpatients, 98 refused to take part in the study. Performance status of patients who refused to take part to a time consuming assessment well described in the consent form was certainly lower than the performance status of included patients. Twenty patients withdrew from assessments for various reasons: three patients considered the duration of the assessment as too long, eight patients considered not being physically able to continue the assessment, three patients considered not being psychologically able to continue the assessment, four patients gave other reasons (personal reasons …). The two last patients gave multiple reasons (duration of evaluation and physical state versus physical, psychological state and other). Nine patients were excluded from statistical analyses because they did not identify their primary caregiver. Thus, analyses included 166 patients who could be admitted in day care or inpatients settings according to their diagnosis and treatments. Table 1 lists patients' sociodemographic, medical, physical functioning status, and psychological (SPB-PC, psychological distress, perceived cognitive function) characteristics.
Prevalence of self-perceived burden to the primary caregiver (SPB-PC) 15% in the second quarter (25-49 mm), and 22% in the lowest quarter (1-24 mm). Twenty-eight percent of patients reported no SPB-PC. Table 2 displays sociodemographic and medical characteristics associated with patients' SPB-PC at the start of chemotherapy. Correlations between SPB-PC and sociodemographic characteristics were not significant. Among medical characteristics, only symptoms (fatigue, pain, nausea, and QOL) were correlated significantly with SPB-PC (r = 0.16 to 0.33). Table 3 lists physical functioning status, psychological, and patient/primary caregiver relationship characteristics associated with SPB-PC. All physical functioning and psychological variables were correlated significantly (r = 0.18 to 0.41). Some data (HADS) were missing for only one patient. No significant association with relationship characteristics was found.
Factors associated with SPB-PC
The backward stepwise linear regression analysis included 12 variables: psychological distress, perceived cognitive impairment, comments from others, perceived cognitive ability, impact of impairments on QOL, QOL, pain, fatigue, nausea, Karnofsky performance score, ADL and IADL scores. Older patients' SPB-PC was associated with low Karnofsky performance score (β = À0.135, p = 0.058), difficulties in ADL (β = À0.148, p = 0.037), psychological distress (β = 0.283, p < 0.001), and perceived cognitive impairments (β = 0.211, p = 0.004). The proportion of explained variance was 23.5% (Table  4) . The results remain the same if the 12 patients receiving bone marrow transplant are not included in the analysis.
It should be underlined that commonly Karnofsky performance score is grouped into 100/70/40 and ADL/IADL scores are categorized into dependency and independency. In order to assess the linearity assumption of these scores, we conducted a further linear regression model with Karnofsky performance score and ADL/IADL scores as categorical variables according to the hereabove recommended categorical scores. Results considering Karnofsky performance score and ADL/IADL scores as categorical variables are quite similar to results considering the scores as continuous variables. It was therefore decided to include these variables in the regression analysis as continuous variables. Finally several logistic regression analyses were conducted to test the output. The results are quite similar to the linear regression results.
Conclusions
This study showed that 35% of older patients with hematologic malignancies experienced moderate to severe SPB-PC (VAS ≥ 50 mm), and that higher levels of SPB-PC were associated with increased functional and psychological difficulties. By contrast, SPB-PC was not associated with patients' medical or patients'/primary caregivers' personal relationship characteristics. The examined characteristics were associated weakly with SPB-PC, explaining about 25% of the variance. These results suggest that SPB-PC is associated with characteristics that were not assessed in this study. This study is the first to show that about one third older patients with cancer experience moderate to severe SPB-PC prior to the side effects of chemotherapy. This study confirms the results of previous studies conducted among patients with chronic pain or terminally illness [21, 23, 26] by showing that older patients with cancer who feel functionally or psychologically impaired may also experience SPB-PC. Participants did not report severe functional, psychological, and cognitive difficulties. Thus, even slight loss of physical functioning status and/or psychological or cognitive difficulties at the time of chemotherapy initiation may be associated with SPB-PC in older patients with cancer.
Surprisingly, we found no association between SPB-PC and the medical characteristics examined. These results may be explained by patients' minimization of the meaning of this type of characteristics, and their expectation that the planned treatment would be effective. Moreover, SPB-PC was not associated with patients'/primary caregivers' personal relationship characteristics examined in this study (e.g. family tie, frequency of encounters, frequency of discussions about difficulties, frequency of caregivers' support, caregivers' ability to perceive patients' difficulties).
Our results have several clinical implications. Health care professionals should be aware that more than one in three older patients may experience moderate to severe SPB-PC at the time of chemotherapy initiation. Professionals should thus be ready to address older patients' SPB, even when they are starting new treatment, and assess underlying factors and consequences in terms of patients' adjustment to treatment and everyday life. When appropriate, health care professionals should also normalize this feeling and adapt their support to the needs of patients and caregivers.
In case of severe SPB-PC with adverse effects on medical decision making, support interventions led by specialized mental health professionals and designed for older patients with cancer should be available and offered. To our knowledge, no recommendation has been designed to specifically support patients experiencing SPB. Potentially useful strategies that could be considered in the development of psychological interventions to support patients' ability to cope with SPB [8] include inviting patients to take more active roles in their care, prepare themselves for future life steps, recognize the needs of others, and increase aware of caregivers' desire to help. These interventions should thus also consider facilitating communication between patients and primary caregivers to reduce the potential feeling of inequity.
To conclude, this study is the first to assess the prevalence of moderate to severe SPB-PC exclusively in older patients with cancer at the time of chemotherapy initiation, and to explore characteristics associated with this feeling. The results indicate that SPB-PC is prevalent and may appear even in the initiation of treatment phase, suggesting that SPB-PC should be assessed and addressed. Future studies should involve more precise investigation of other factors potentially underlying SPB-PC, such as perceived efficacy of treatment, financial difficulties, primary caregivers' distress, reciprocity, inequity, guilt, values, social norms, self-esteem, personality traits and past history. Further research should also investigate the effects of SPB-PC on outcomes such as medical decision making, treatment compliance, and place of care in older patients with cancer. Finally future studies should also investigate similarities and differences in patients' and primary caregivers' reports of SPB-PC. The results of such studies may allow to better understand the family caregivers' perception and may be helpful to organize the support of patient/primary caregiver dyad.
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